 | • レポートコード：QAF27756 • 出版社/出版日：QYResearch / 2021年4月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、148ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の大容量非経口医薬品（LVP）市場について種類別（ソフトバッグLVP、ペットボトルLVP、ガラス瓶LVP）、用途別（一般注入、治療的注入、高栄養価注入）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・大容量非経口医薬品（LVP）市場の概要 ・世界の主要地域別大容量非経口医薬品（LVP）市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の大容量非経口医薬品（LVP）市場規模2016-2021：種類別（ソフトバッグLVP、ペットボトルLVP、ガラス瓶LVP） ・世界の大容量非経口医薬品（LVP）市場予測2012-2027：種類別（ソフトバッグLVP、ペットボトルLVP、ガラス瓶LVP） ・世界の大容量非経口医薬品（LVP）市場規模2016-2021：用途別（一般注入、治療的注入、高栄養価注入） ・世界の大容量非経口医薬品（LVP）市場予測2012-2027：用途別（一般注入、治療的注入、高栄養価注入） ・大容量非経口医薬品（LVP）のアメリカ市場規模と予測2016-2021 ・大容量非経口医薬品（LVP）のヨーロッパ市場規模と予測2016-2021 ・大容量非経口医薬品（LVP）の中国市場規模と予測2016-2021 ・大容量非経口医薬品（LVP）の日本市場規模と予測2016-2021 ・大容量非経口医薬品（LVP）の東南アジア市場規模と予測2016-2021 ・大容量非経口医薬品（LVP）のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Baxter Healthcare、Kelun Pharma、B. Braun、Fresenius、Teva Pharmaceutical Industries、Pfizer (Hospira)、Ostuka Pharmaceutical、CR Double-Crane、Pisa、Huaren、Patheon、Aspen Holdings、Beximco Pharma、Cook Pharmica、Albert David、PSI Ltd、Ozon Pharmaceuticals、BAG Healthcare、BML Parenteral Drugs） ・大容量非経口医薬品（LVP）の製造コスト分析 ・販売チャネル、流通業者、顧客 ・大容量非経口医薬品（LVP）の市場動向・機会・課題 ・調査の結論 |
Large volume parenterals or LVPs (sometimes called large volume injections) are aqueous solutions usually supplied in volumes of at least 100 ml with sizes of 250 ml, 500 ml, 1000 ml, 3000 ml, and 5000 ml most common. Directions usually recommend that large quantities be administered.
Parenteral preparations are sterile, solid dosage form or pyrogen-free liquids, which contain one or more number of active ingredients boxed in single or multi dose containers. They are meant to be administered either by infusion, transplantation or injection in the body.
Parenteral formulations are classified into small and large based on their volume. Small volume parenteral formulations are 100ml or more and can be given as single or multi dose, whereas large volume parenteral preparations are more than 100ml, intended for single use.
The first main kind is Soft Bag LVP, it hold a comparatively larger share in global market, which accounts for about 61.37% in 2018.
Another main kind is Glass Bottle LVP, for many companies, Glass Bottle LVP is attractive because of the market consumption need in the future. The Glass Bottle LVP share the rest 22.34% market share in 2018.
Plastic Bottle LVP hold the rest share, which accounts for about 16.29% in 2018.From the view of region, Asia-Pacific have a larger market share in 2018 which account for 46.29%, and will witness a stable growth in following years. North America and Europe hold a market share of 25.63% and 23.99% will still play an important role which cannot be ignored. Any changes from North America and Europe might affect the development trend of Large Volume Parenteral (LVP). South America and Middle East & Africa also play important roles in global market, but it will witness the comparatively low market share within selected regions.
Market Analysis and Insights: Global Large Volume Parenteral (LVP) Market
The global Large Volume Parenteral (LVP) market was valued at US$ 12750 in 2020 and will reach US$ 21150 million by the end of 2027, growing at a CAGR of 8.8% during 2022-2027.
Global Large Volume Parenteral (LVP) Scope and Market Size
The global Large Volume Parenteral (LVP) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Large Volume Parenteral (LVP) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Soft Bag LVP
Plastic Bottle LVP
Glass Bottle LVP
In 2018, Soft Bag LVP accounted for a major share of 61% in the global Large Volume Parenteral (LVP) market. And this product segment is poised to reach 15402 M Units by 2024 from 13868 M Units in 2019.
Segment by Application
Basic Infusion
Therapeutic Infusion
Nutritious Infusion
The Large Volume Parenteral (LVP) market is analysed and market size information is provided by regions (countries). Segment by Application, the Large Volume Parenteral (LVP) market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Baxter Healthcare
Kelun Pharma
B. Braun
Fresenius
Teva Pharmaceutical Industries
Pfizer (Hospira)
Ostuka Pharmaceutical
CR Double-Crane
Pisa
Huaren
Patheon
Aspen Holdings
Beximco Pharma
Cook Pharmica
Albert David
PSI Ltd
Ozon Pharmaceuticals
BAG Healthcare
BML Parenteral Drugs
1 Large Volume Parenteral (LVP) Market Overview
1.1 Large Volume Parenteral (LVP) Product Scope
1.2 Large Volume Parenteral (LVP) Segment by Type
1.2.1 Global Large Volume Parenteral (LVP) Sales by Type (2016 & 2021 & 2027)
1.2.2 Soft Bag LVP
1.2.3 Plastic Bottle LVP
1.2.4 Glass Bottle LVP
1.3 Large Volume Parenteral (LVP) Segment by Application
1.3.1 Global Large Volume Parenteral (LVP) Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Basic Infusion
1.3.3 Therapeutic Infusion
1.3.4 Nutritious Infusion
1.4 Large Volume Parenteral (LVP) Market Estimates and Forecasts (2016-2027)
1.4.1 Global Large Volume Parenteral (LVP) Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Large Volume Parenteral (LVP) Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Large Volume Parenteral (LVP) Price Trends (2016-2027)
2 Large Volume Parenteral (LVP) Estimates and Forecasts by Region
2.1 Global Large Volume Parenteral (LVP) Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Large Volume Parenteral (LVP) Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Large Volume Parenteral (LVP) Sales Market Share by Region (2016-2021)
2.2.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Region (2016-2021)
2.3 Global Large Volume Parenteral (LVP) Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Large Volume Parenteral (LVP) Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Large Volume Parenteral (LVP) Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Large Volume Parenteral (LVP) Estimates and Projections (2016-2027)
2.4.2 Europe Large Volume Parenteral (LVP) Estimates and Projections (2016-2027)
2.4.3 China Large Volume Parenteral (LVP) Estimates and Projections (2016-2027)
2.4.4 Japan Large Volume Parenteral (LVP) Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Large Volume Parenteral (LVP) Estimates and Projections (2016-2027)
2.4.6 India Large Volume Parenteral (LVP) Estimates and Projections (2016-2027)
3 Global Large Volume Parenteral (LVP) Competition Landscape by Players
3.1 Global Top Large Volume Parenteral (LVP) Players by Sales (2016-2021)
3.2 Global Top Large Volume Parenteral (LVP) Players by Revenue (2016-2021)
3.3 Global Large Volume Parenteral (LVP) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Large Volume Parenteral (LVP) as of 2020)
3.4 Global Large Volume Parenteral (LVP) Average Price by Company (2016-2021)
3.5 Manufacturers Large Volume Parenteral (LVP) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Large Volume Parenteral (LVP) Market Size by Type
4.1 Global Large Volume Parenteral (LVP) Historic Market Review by Type (2016-2021)
4.1.1 Global Large Volume Parenteral (LVP) Sales Market Share by Type (2016-2021)
4.1.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Type (2016-2021)
4.1.3 Global Large Volume Parenteral (LVP) Price by Type (2016-2021)
4.2 Global Large Volume Parenteral (LVP) Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Large Volume Parenteral (LVP) Sales Forecast by Type (2022-2027)
4.2.2 Global Large Volume Parenteral (LVP) Revenue Forecast by Type (2022-2027)
4.2.3 Global Large Volume Parenteral (LVP) Price Forecast by Type (2022-2027)
5 Global Large Volume Parenteral (LVP) Market Size by Application
5.1 Global Large Volume Parenteral (LVP) Historic Market Review by Application (2016-2021)
5.1.1 Global Large Volume Parenteral (LVP) Sales Market Share by Application (2016-2021)
5.1.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Application (2016-2021)
5.1.3 Global Large Volume Parenteral (LVP) Price by Application (2016-2021)
5.2 Global Large Volume Parenteral (LVP) Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Large Volume Parenteral (LVP) Sales Forecast by Application (2022-2027)
5.2.2 Global Large Volume Parenteral (LVP) Revenue Forecast by Application (2022-2027)
5.2.3 Global Large Volume Parenteral (LVP) Price Forecast by Application (2022-2027)
6 North America Large Volume Parenteral (LVP) Market Facts & Figures
6.1 North America Large Volume Parenteral (LVP) Sales by Company
6.1.1 North America Large Volume Parenteral (LVP) Sales by Company (2016-2021)
6.1.2 North America Large Volume Parenteral (LVP) Revenue by Company (2016-2021)
6.2 North America Large Volume Parenteral (LVP) Sales Breakdown by Type
6.2.1 North America Large Volume Parenteral (LVP) Sales Breakdown by Type (2016-2021)
6.2.2 North America Large Volume Parenteral (LVP) Sales Breakdown by Type (2022-2027)
6.3 North America Large Volume Parenteral (LVP) Sales Breakdown by Application
6.3.1 North America Large Volume Parenteral (LVP) Sales Breakdown by Application (2016-2021)
6.3.2 North America Large Volume Parenteral (LVP) Sales Breakdown by Application (2022-2027)
7 Europe Large Volume Parenteral (LVP) Market Facts & Figures
7.1 Europe Large Volume Parenteral (LVP) Sales by Company
7.1.1 Europe Large Volume Parenteral (LVP) Sales by Company (2016-2021)
7.1.2 Europe Large Volume Parenteral (LVP) Revenue by Company (2016-2021)
7.2 Europe Large Volume Parenteral (LVP) Sales Breakdown by Type
7.2.1 Europe Large Volume Parenteral (LVP) Sales Breakdown by Type (2016-2021)
7.2.2 Europe Large Volume Parenteral (LVP) Sales Breakdown by Type (2022-2027)
7.3 Europe Large Volume Parenteral (LVP) Sales Breakdown by Application
7.3.1 Europe 148 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 148 Sales Breakdown by Application (2022-2027)
8 China Large Volume Parenteral (LVP) Market Facts & Figures
8.1 China Large Volume Parenteral (LVP) Sales by Company
8.1.1 China Large Volume Parenteral (LVP) Sales by Company (2016-2021)
8.1.2 China Large Volume Parenteral (LVP) Revenue by Company (2016-2021)
8.2 China Large Volume Parenteral (LVP) Sales Breakdown by Type
8.2.1 China Large Volume Parenteral (LVP) Sales Breakdown by Type (2016-2021)
8.2.2 China Large Volume Parenteral (LVP) Sales Breakdown by Type (2022-2027)
8.3 China Large Volume Parenteral (LVP) Sales Breakdown by Application
8.3.1 China 316 Sales Breakdown by Application (2016-2021)
8.3.2 China 316 Sales Breakdown by Application (2022-2027)
9 Japan Large Volume Parenteral (LVP) Market Facts & Figures
9.1 Japan Large Volume Parenteral (LVP) Sales by Company
9.1.1 Japan Large Volume Parenteral (LVP) Sales by Company (2016-2021)
9.1.2 Japan Large Volume Parenteral (LVP) Revenue by Company (2016-2021)
9.2 Japan Large Volume Parenteral (LVP) Sales Breakdown by Type
9.2.1 Japan Large Volume Parenteral (LVP) Sales Breakdown by Type (2016-2021)
9.2.2 Japan Large Volume Parenteral (LVP) Sales Breakdown by Type (2022-2027)
9.3 Japan Large Volume Parenteral (LVP) Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Large Volume Parenteral (LVP) Market Facts & Figures
10.1 Southeast Asia Large Volume Parenteral (LVP) Sales by Company
10.1.1 Southeast Asia Large Volume Parenteral (LVP) Sales by Company (2016-2021)
10.1.2 Southeast Asia Large Volume Parenteral (LVP) Revenue by Company (2016-2021)
10.2 Southeast Asia Large Volume Parenteral (LVP) Sales Breakdown by Type
10.2.1 Southeast Asia Large Volume Parenteral (LVP) Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Large Volume Parenteral (LVP) Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Large Volume Parenteral (LVP) Sales Breakdown by Application
10.3.1 Southeast Asia M Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia M Units Sales Breakdown by Application (2022-2027)
11 India Large Volume Parenteral (LVP) Market Facts & Figures
11.1 India Large Volume Parenteral (LVP) Sales by Company
11.1.1 India Large Volume Parenteral (LVP) Sales by Company (2016-2021)
11.1.2 India Large Volume Parenteral (LVP) Revenue by Company (2016-2021)
11.2 India Large Volume Parenteral (LVP) Sales Breakdown by Type
11.2.1 India Large Volume Parenteral (LVP) Sales Breakdown by Type (2016-2021)
11.2.2 India Large Volume Parenteral (LVP) Sales Breakdown by Type (2022-2027)
11.3 India Large Volume Parenteral (LVP) Sales Breakdown by Application
11.3.1 India Large Volume Parenteral (LVP) Sales Breakdown by Application (2016-2021)
11.3.2 India Large Volume Parenteral (LVP) Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Large Volume Parenteral (LVP) Business
12.1 Baxter Healthcare
12.1.1 Baxter Healthcare Corporation Information
12.1.2 Baxter Healthcare Business Overview
12.1.3 Baxter Healthcare Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Baxter Healthcare Large Volume Parenteral (LVP) Products Offered
12.1.5 Baxter Healthcare Recent Development
12.2 Kelun Pharma
12.2.1 Kelun Pharma Corporation Information
12.2.2 Kelun Pharma Business Overview
12.2.3 Kelun Pharma Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Kelun Pharma Large Volume Parenteral (LVP) Products Offered
12.2.5 Kelun Pharma Recent Development
12.3 B. Braun
12.3.1 B. Braun Corporation Information
12.3.2 B. Braun Business Overview
12.3.3 B. Braun Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 B. Braun Large Volume Parenteral (LVP) Products Offered
12.3.5 B. Braun Recent Development
12.4 Fresenius
12.4.1 Fresenius Corporation Information
12.4.2 Fresenius Business Overview
12.4.3 Fresenius Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Fresenius Large Volume Parenteral (LVP) Products Offered
12.4.5 Fresenius Recent Development
12.5 Teva Pharmaceutical Industries
12.5.1 Teva Pharmaceutical Industries Corporation Information
12.5.2 Teva Pharmaceutical Industries Business Overview
12.5.3 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Products Offered
12.5.5 Teva Pharmaceutical Industries Recent Development
12.6 Pfizer (Hospira)
12.6.1 Pfizer (Hospira) Corporation Information
12.6.2 Pfizer (Hospira) Business Overview
12.6.3 Pfizer (Hospira) Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Pfizer (Hospira) Large Volume Parenteral (LVP) Products Offered
12.6.5 Pfizer (Hospira) Recent Development
12.7 Ostuka Pharmaceutical
12.7.1 Ostuka Pharmaceutical Corporation Information
12.7.2 Ostuka Pharmaceutical Business Overview
12.7.3 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Products Offered
12.7.5 Ostuka Pharmaceutical Recent Development
12.8 CR Double-Crane
12.8.1 CR Double-Crane Corporation Information
12.8.2 CR Double-Crane Business Overview
12.8.3 CR Double-Crane Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.8.4 CR Double-Crane Large Volume Parenteral (LVP) Products Offered
12.8.5 CR Double-Crane Recent Development
12.9 Pisa
12.9.1 Pisa Corporation Information
12.9.2 Pisa Business Overview
12.9.3 Pisa Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Pisa Large Volume Parenteral (LVP) Products Offered
12.9.5 Pisa Recent Development
12.10 Huaren
12.10.1 Huaren Corporation Information
12.10.2 Huaren Business Overview
12.10.3 Huaren Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Huaren Large Volume Parenteral (LVP) Products Offered
12.10.5 Huaren Recent Development
12.11 Patheon
12.11.1 Patheon Corporation Information
12.11.2 Patheon Business Overview
12.11.3 Patheon Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Patheon Large Volume Parenteral (LVP) Products Offered
12.11.5 Patheon Recent Development
12.12 Aspen Holdings
12.12.1 Aspen Holdings Corporation Information
12.12.2 Aspen Holdings Business Overview
12.12.3 Aspen Holdings Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Aspen Holdings Large Volume Parenteral (LVP) Products Offered
12.12.5 Aspen Holdings Recent Development
12.13 Beximco Pharma
12.13.1 Beximco Pharma Corporation Information
12.13.2 Beximco Pharma Business Overview
12.13.3 Beximco Pharma Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Beximco Pharma Large Volume Parenteral (LVP) Products Offered
12.13.5 Beximco Pharma Recent Development
12.14 Cook Pharmica
12.14.1 Cook Pharmica Corporation Information
12.14.2 Cook Pharmica Business Overview
12.14.3 Cook Pharmica Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Cook Pharmica Large Volume Parenteral (LVP) Products Offered
12.14.5 Cook Pharmica Recent Development
12.15 Albert David
12.15.1 Albert David Corporation Information
12.15.2 Albert David Business Overview
12.15.3 Albert David Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Albert David Large Volume Parenteral (LVP) Products Offered
12.15.5 Albert David Recent Development
12.16 PSI Ltd
12.16.1 PSI Ltd Corporation Information
12.16.2 PSI Ltd Business Overview
12.16.3 PSI Ltd Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.16.4 PSI Ltd Large Volume Parenteral (LVP) Products Offered
12.16.5 PSI Ltd Recent Development
12.17 Ozon Pharmaceuticals
12.17.1 Ozon Pharmaceuticals Corporation Information
12.17.2 Ozon Pharmaceuticals Business Overview
12.17.3 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Products Offered
12.17.5 Ozon Pharmaceuticals Recent Development
12.18 BAG Healthcare
12.18.1 BAG Healthcare Corporation Information
12.18.2 BAG Healthcare Business Overview
12.18.3 BAG Healthcare Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.18.4 BAG Healthcare Large Volume Parenteral (LVP) Products Offered
12.18.5 BAG Healthcare Recent Development
12.19 BML Parenteral Drugs
12.19.1 BML Parenteral Drugs Corporation Information
12.19.2 BML Parenteral Drugs Business Overview
12.19.3 BML Parenteral Drugs Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.19.4 BML Parenteral Drugs Large Volume Parenteral (LVP) Products Offered
12.19.5 BML Parenteral Drugs Recent Development
13 Large Volume Parenteral (LVP) Manufacturing Cost Analysis
13.1 Large Volume Parenteral (LVP) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Large Volume Parenteral (LVP)
13.4 Large Volume Parenteral (LVP) Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Large Volume Parenteral (LVP) Distributors List
14.3 Large Volume Parenteral (LVP) Customers
15 Market Dynamics
15.1 Large Volume Parenteral (LVP) Market Trends
15.2 Large Volume Parenteral (LVP) Drivers
15.3 Large Volume Parenteral (LVP) Market Challenges
15.4 Large Volume Parenteral (LVP) Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Large Volume Parenteral (LVP) Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Large Volume Parenteral (LVP) Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Large Volume Parenteral (LVP) Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Large Volume Parenteral (LVP) Sales (M Units) by Region (2016-2021)
Table 5. Global Large Volume Parenteral (LVP) Sales Market Share by Region (2016-2021)
Table 6. Global Large Volume Parenteral (LVP) Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Large Volume Parenteral (LVP) Revenue Share by Region (2016-2021)
Table 8. Global Large Volume Parenteral (LVP) Sales (M Units) Forecast by Region (2022-2027)
Table 9. Global Large Volume Parenteral (LVP) Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Large Volume Parenteral (LVP) Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Large Volume Parenteral (LVP) Revenue Share Forecast by Region (2022-2027)
Table 12. Global Large Volume Parenteral (LVP) Sales (M Units) of Key Companies (2016-2021)
Table 13. Global Large Volume Parenteral (LVP) Sales Share by Company (2016-2021)
Table 14. Global Large Volume Parenteral (LVP) Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Large Volume Parenteral (LVP) Revenue Share by Company (2016-2021)
Table 16. Global Large Volume Parenteral (LVP) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Large Volume Parenteral (LVP) as of 2020)
Table 17. Global Large Volume Parenteral (LVP) Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Large Volume Parenteral (LVP) Manufacturing Sites and Area Served
Table 19. Manufacturers Large Volume Parenteral (LVP) Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Large Volume Parenteral (LVP) Sales (M Units) by Type (2016-2021)
Table 22. Global Large Volume Parenteral (LVP) Sales Share by Type (2016-2021)
Table 23. Global Large Volume Parenteral (LVP) Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Large Volume Parenteral (LVP) Price (USD/Unit) by Type (2016-2021)
Table 25. Global Large Volume Parenteral (LVP) Sales Share by Type (2022-2027)
Table 26. Global Large Volume Parenteral (LVP) Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Large Volume Parenteral (LVP) Revenue Share by Type (2022-2027)
Table 28. Global Large Volume Parenteral (LVP) Price (USD/Unit) by Type (2022-2027)
Table 29. Global Large Volume Parenteral (LVP) Sales (M Units) by Application (2016-2021)
Table 30. Global Large Volume Parenteral (LVP) Sales Share by Application (2016-2021)
Table 31. Global Large Volume Parenteral (LVP) Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Large Volume Parenteral (LVP) Price (USD/Unit) by Application (2016-2021)
Table 33. Global Large Volume Parenteral (LVP) Sales (M Units) by Application (2022-2027)
Table 34. Global Large Volume Parenteral (LVP) Sales Share by Application (2022-2027)
Table 35. Global Large Volume Parenteral (LVP) Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Large Volume Parenteral (LVP) Revenue Share by Application (2022-2027)
Table 37. Global Large Volume Parenteral (LVP) Price (USD/Unit) by Application (2022-2027)
Table 38. North America Large Volume Parenteral (LVP) Sales (M Units) by Company (2016-2021)
Table 39. North America Large Volume Parenteral (LVP) Sales Market Share by Company (2016-2021)
Table 40. North America Large Volume Parenteral (LVP) Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Large Volume Parenteral (LVP) Revenue Market Share by Company (2016-2021)
Table 42. North America Large Volume Parenteral (LVP) Sales by Type (2016-2021) & (M Units)
Table 43. North America Large Volume Parenteral (LVP) Sales Market Share by Type (2016-2021)
Table 44. North America Large Volume Parenteral (LVP) Sales by Type (2022-2027) & (M Units)
Table 45. North America Large Volume Parenteral (LVP) Sales Market Share by Type (2022-2027)
Table 46. North America Large Volume Parenteral (LVP) Sales by Application (2016-2021) & (M Units)
Table 47. North America Large Volume Parenteral (LVP) Sales Market Share by Application (2016-2021)
Table 48. North America Large Volume Parenteral (LVP) Sales by Application (2022-2027) & (M Units)
Table 49. North America Large Volume Parenteral (LVP) Sales Market Share by Application (2022-2027)
Table 50. Europe Large Volume Parenteral (LVP) Sales (M Units) by Company (2016-2021)
Table 51. Europe Large Volume Parenteral (LVP) Sales Market Share by Company (2016-2021)
Table 52. Europe Large Volume Parenteral (LVP) Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Large Volume Parenteral (LVP) Revenue Market Share by Company (2016-2021)
Table 54. Europe Large Volume Parenteral (LVP) Sales by Type (2016-2021) & (M Units)
Table 55. Europe Large Volume Parenteral (LVP) Sales Market Share by Type (2016-2021)
Table 56. Europe Large Volume Parenteral (LVP) Sales by Type (2022-2027) & (M Units)
Table 57. Europe Large Volume Parenteral (LVP) Sales Market Share by Type (2022-2027)
Table 58. Europe Large Volume Parenteral (LVP) Sales by Application (2016-2021) & (M Units)
Table 59. Europe Large Volume Parenteral (LVP) Sales Market Share by Application (2016-2021)
Table 60. Europe Large Volume Parenteral (LVP) Sales by Application (2022-2027) & (M Units)
Table 61. Europe Large Volume Parenteral (LVP) Sales Market Share by Application (2022-2027)
Table 62. China Large Volume Parenteral (LVP) Sales (M Units) by Company (2016-2021)
Table 63. China Large Volume Parenteral (LVP) Sales Market Share by Company (2016-2021)
Table 64. China Large Volume Parenteral (LVP) Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Large Volume Parenteral (LVP) Revenue Market Share by Company (2016-2021)
Table 66. China Large Volume Parenteral (LVP) Sales by Type (2016-2021) & (M Units)
Table 67. China Large Volume Parenteral (LVP) Sales Market Share by Type (2016-2021)
Table 68. China Large Volume Parenteral (LVP) Sales by Type (2022-2027) & (M Units)
Table 69. China Large Volume Parenteral (LVP) Sales Market Share by Type (2022-2027)
Table 70. China Large Volume Parenteral (LVP) Sales by Application (2016-2021) & (M Units)
Table 71. China Large Volume Parenteral (LVP) Sales Market Share by Application (2016-2021)
Table 72. China Large Volume Parenteral (LVP) Sales by Application (2022-2027) & (M Units)
Table 73. China Large Volume Parenteral (LVP) Sales Market Share by Application (2022-2027)
Table 74. Japan Large Volume Parenteral (LVP) Sales (M Units) by Company (2016-2021)
Table 75. Japan Large Volume Parenteral (LVP) Sales Market Share by Company (2016-2021)
Table 76. Japan Large Volume Parenteral (LVP) Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Large Volume Parenteral (LVP) Revenue Market Share by Company (2016-2021)
Table 78. Japan Large Volume Parenteral (LVP) Sales by Type (2016-2021) & (M Units)
Table 79. Japan Large Volume Parenteral (LVP) Sales Market Share by Type (2016-2021)
Table 80. Japan Large Volume Parenteral (LVP) Sales by Type (2022-2027) & (M Units)
Table 81. Japan Large Volume Parenteral (LVP) Sales Market Share by Type (2022-2027)
Table 82. Japan Large Volume Parenteral (LVP) Sales by Application (2016-2021) & (M Units)
Table 83. Japan Large Volume Parenteral (LVP) Sales Market Share by Application (2016-2021)
Table 84. Japan Large Volume Parenteral (LVP) Sales by Application (2022-2027) & (M Units)
Table 85. Japan Large Volume Parenteral (LVP) Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Large Volume Parenteral (LVP) Sales (M Units) by Company (2016-2021)
Table 87. Southeast Asia Large Volume Parenteral (LVP) Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Large Volume Parenteral (LVP) Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Large Volume Parenteral (LVP) Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Large Volume Parenteral (LVP) Sales by Type (2016-2021) & (M Units)
Table 91. Southeast Asia Large Volume Parenteral (LVP) Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Large Volume Parenteral (LVP) Sales by Type (2022-2027) & (M Units)
Table 93. Southeast Asia Large Volume Parenteral (LVP) Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Large Volume Parenteral (LVP) Sales by Application (2016-2021) & (M Units)
Table 95. Southeast Asia Large Volume Parenteral (LVP) Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Large Volume Parenteral (LVP) Sales by Application (2022-2027) & (M Units)
Table 97. Southeast Asia Large Volume Parenteral (LVP) Sales Market Share by Application (2022-2027)
Table 98. India Large Volume Parenteral (LVP) Sales (M Units) by Company (2016-2021)
Table 99. India Large Volume Parenteral (LVP) Sales Market Share by Company (2016-2021)
Table 100. India Large Volume Parenteral (LVP) Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Large Volume Parenteral (LVP) Revenue Market Share by Company (2016-2021)
Table 102. India Large Volume Parenteral (LVP) Sales by Type (2016-2021) & (M Units)
Table 103. India Large Volume Parenteral (LVP) Sales Market Share by Type (2016-2021)
Table 104. India Large Volume Parenteral (LVP) Sales by Type (2022-2027) & (M Units)
Table 105. India Large Volume Parenteral (LVP) Sales Market Share by Type (2022-2027)
Table 106. India Large Volume Parenteral (LVP) Sales by Application (2016-2021) & (M Units)
Table 107. India Large Volume Parenteral (LVP) Sales Market Share by Application (2016-2021)
Table 108. India Large Volume Parenteral (LVP) Sales by Application (2022-2027) & (M Units)
Table 109. India Large Volume Parenteral (LVP) Sales Market Share by Application (2022-2027)
Table 110. Baxter Healthcare Corporation Information
Table 111. Baxter Healthcare Description and Business Overview
Table 112. Baxter Healthcare Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Baxter Healthcare Large Volume Parenteral (LVP) Product
Table 114. Baxter Healthcare Recent Development
Table 115. Kelun Pharma Corporation Information
Table 116. Kelun Pharma Description and Business Overview
Table 117. Kelun Pharma Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Kelun Pharma Large Volume Parenteral (LVP) Product
Table 119. Kelun Pharma Recent Development
Table 120. B. Braun Corporation Information
Table 121. B. Braun Description and Business Overview
Table 122. B. Braun Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. B. Braun Large Volume Parenteral (LVP) Product
Table 124. B. Braun Recent Development
Table 125. Fresenius Corporation Information
Table 126. Fresenius Description and Business Overview
Table 127. Fresenius Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Fresenius Large Volume Parenteral (LVP) Product
Table 129. Fresenius Recent Development
Table 130. Teva Pharmaceutical Industries Corporation Information
Table 131. Teva Pharmaceutical Industries Description and Business Overview
Table 132. Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Product
Table 134. Teva Pharmaceutical Industries Recent Development
Table 135. Pfizer (Hospira) Corporation Information
Table 136. Pfizer (Hospira) Description and Business Overview
Table 137. Pfizer (Hospira) Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Pfizer (Hospira) Large Volume Parenteral (LVP) Product
Table 139. Pfizer (Hospira) Recent Development
Table 140. Ostuka Pharmaceutical Corporation Information
Table 141. Ostuka Pharmaceutical Description and Business Overview
Table 142. Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Ostuka Pharmaceutical Large Volume Parenteral (LVP) Product
Table 144. Ostuka Pharmaceutical Recent Development
Table 145. CR Double-Crane Corporation Information
Table 146. CR Double-Crane Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. CR Double-Crane Description and Business Overview
Table 148. CR Double-Crane Large Volume Parenteral (LVP) Product
Table 149. CR Double-Crane Recent Development
Table 150. Pisa Corporation Information
Table 151. Pisa Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Pisa Description and Business Overview
Table 153. Pisa Large Volume Parenteral (LVP) Product
Table 154. Pisa Recent Development
Table 155. Huaren Corporation Information
Table 156. Huaren Description and Business Overview
Table 157. Huaren Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. Huaren Large Volume Parenteral (LVP) Product
Table 159. Huaren Recent Development
Table 160. Patheon Corporation Information
Table 161. Patheon Description and Business Overview
Table 162. Patheon Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 163. Patheon Large Volume Parenteral (LVP) Product
Table 164. Patheon Recent Development
Table 165. Aspen Holdings Corporation Information
Table 166. Aspen Holdings Description and Business Overview
Table 167. Aspen Holdings Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 168. Aspen Holdings Large Volume Parenteral (LVP) Product
Table 169. Aspen Holdings Recent Development
Table 170. Beximco Pharma Corporation Information
Table 171. Beximco Pharma Description and Business Overview
Table 172. Beximco Pharma Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 173. Beximco Pharma Large Volume Parenteral (LVP) Product
Table 174. Beximco Pharma Recent Development
Table 175. Cook Pharmica Corporation Information
Table 176. Cook Pharmica Description and Business Overview
Table 177. Cook Pharmica Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 178. Cook Pharmica Large Volume Parenteral (LVP) Product
Table 179. Cook Pharmica Recent Development
Table 180. Albert David Corporation Information
Table 181. Albert David Description and Business Overview
Table 182. Albert David Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 183. Albert David Large Volume Parenteral (LVP) Product
Table 184. Albert David Recent Development
Table 185. PSI Ltd Corporation Information
Table 186. PSI Ltd Description and Business Overview
Table 187. PSI Ltd Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 188. PSI Ltd Large Volume Parenteral (LVP) Product
Table 189. PSI Ltd Recent Development
Table 190. Ozon Pharmaceuticals Corporation Information
Table 191. Ozon Pharmaceuticals Description and Business Overview
Table 192. Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 193. Ozon Pharmaceuticals Large Volume Parenteral (LVP) Product
Table 194. Ozon Pharmaceuticals Recent Development
Table 195. BAG Healthcare Corporation Information
Table 196. BAG Healthcare Description and Business Overview
Table 197. BAG Healthcare Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 198. BAG Healthcare Large Volume Parenteral (LVP) Product
Table 199. BAG Healthcare Recent Development
Table 200. BML Parenteral Drugs Corporation Information
Table 201. BML Parenteral Drugs Description and Business Overview
Table 202. BML Parenteral Drugs Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 203. BML Parenteral Drugs Large Volume Parenteral (LVP) Product
Table 204. BML Parenteral Drugs Recent Development
Table 205. Production Base and Market Concentration Rate of Raw Material
Table 206. Key Suppliers of Raw Materials
Table 207. Large Volume Parenteral (LVP) Distributors List
Table 208. Large Volume Parenteral (LVP) Customers List
Table 209. Large Volume Parenteral (LVP) Market Trends
Table 210. Large Volume Parenteral (LVP) Market Drivers
Table 211. Large Volume Parenteral (LVP) Market Challenges
Table 212. Large Volume Parenteral (LVP) Market Restraints
Table 213. Research Programs/Design for This Report
Table 214. Key Data Information from Secondary Sources
Table 215. Key Data Information from Primary Sources
List of Figures
Figure 1. Large Volume Parenteral (LVP) Product Picture
Figure 2. Global Large Volume Parenteral (LVP) Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Large Volume Parenteral (LVP) Sales Market Share by Application in 2021 & 2027
Figure 6. Basic Infusion Examples
Figure 7. Therapeutic Infusion Examples
Figure 8. Nutritious Infusion Examples
Figure 9. Global Large Volume Parenteral (LVP) Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Large Volume Parenteral (LVP) Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Large Volume Parenteral (LVP) Sales (M Units) Growth Rate (2016-2027)
Figure 12. Global Large Volume Parenteral (LVP) Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 13. Global Large Volume Parenteral (LVP) Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Large Volume Parenteral (LVP) Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Large Volume Parenteral (LVP) Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Large Volume Parenteral (LVP) Sales (M Units) Growth Rate (2016-2027)
Figure 17. Europe Large Volume Parenteral (LVP) Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Large Volume Parenteral (LVP) Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Large Volume Parenteral (LVP) Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Large Volume Parenteral (LVP) Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Large Volume Parenteral (LVP) Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Large Volume Parenteral (LVP) Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Large Volume Parenteral (LVP) Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Large Volume Parenteral (LVP) Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Large Volume Parenteral (LVP) Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Large Volume Parenteral (LVP) Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Large Volume Parenteral (LVP) Players Market Share by Revenue in Large Volume Parenteral (LVP): 2016 & 2020
Figure 28. Large Volume Parenteral (LVP) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Large Volume Parenteral (LVP) Revenue Share by Type (2016-2021)
Figure 30. Global Large Volume Parenteral (LVP) Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Large Volume Parenteral (LVP) Revenue Share by Application (2016-2021)
Figure 32. Global Large Volume Parenteral (LVP) Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Large Volume Parenteral (LVP) Sales Market Share by Type in 2020
Figure 34. North America Large Volume Parenteral (LVP) Sales Market Share by Application in 2020
Figure 35. Europe Large Volume Parenteral (LVP) Sales Market Share by Type in 2020
Figure 36. Europe Large Volume Parenteral (LVP) Sales Market Share by Application in 2020
Figure 37. China Large Volume Parenteral (LVP) Sales Market Share by Type in 2020
Figure 38. China Large Volume Parenteral (LVP) Sales Market Share by Application in 2020
Figure 39. Japan Large Volume Parenteral (LVP) Sales Market Share by Type in 2020
Figure 40. Japan Large Volume Parenteral (LVP) Sales Market Share by Application in 2020
Figure 41. Southeast Asia Large Volume Parenteral (LVP) Sales Market Share by Type in 2020
Figure 42. Southeast Asia Large Volume Parenteral (LVP) Sales Market Share by Application in 2020
Figure 43. India Large Volume Parenteral (LVP) Sales Market Share by Type in 2020
Figure 44. India Large Volume Parenteral (LVP) Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Large Volume Parenteral (LVP)
Figure 47. Manufacturing Process Analysis of Large Volume Parenteral (LVP)
Figure 48. Large Volume Parenteral (LVP) Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
世界の非経口栄養溶液市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Parenteral Nutrition Solutions Market The global Parenteral Nutrition Solutions market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data int…- 世界の非侵襲的非経口スクリーニング市場規模・現状・予測（2021年-2027年） Non-invasive Parenteral Screening is a nascent genetic process of examining a fetal cell free DNA present in the mothers blood serum for detecting common fetal aneuploidies. Its main objective is early detection of genetic disorders such as trisomy 21 (Down syndrome), trisomy 18 (Edward syndrome), t…
- 非侵襲的非経口スクリーニングのグローバル市場：規模・現状・予測2019-2025 Non-invasive Parenteral Screening is a nascent genetic process of examining a fetal cell free DNA present in the mothers blood serum for detecting common fetal aneuploidies. Its main objective is early detection of genetic disorders such as trisomy 21 (Down syndrome), trisomy 18 (Edward syndrome), t…
- 非侵襲的非経口スクリーニングのグローバル市場：規模・現状・予測2019-2025 Non-invasive Parenteral Screening is a nascent genetic process of examining a fetal cell free DNA present in the mothers blood serum for detecting common fetal aneuploidies. Its main objective is early detection of genetic disorders such as trisomy 21 (Down syndrome), trisomy 18 (Edward syndrome), t…
- 世界の非侵襲的非経口スクリーニング器具産業調査2019-2025 Non-invasive Parenteral Screening is a nascent genetic process of examining a fetal cell free DNA present in the mothers blood serum for detecting common fetal aneuploidies. Its main objective is early detection of genetic disorders such as trisomy 21 (Down syndrome), trisomy 18 (Edward syndrome), t…